Showing results (301-310 of 350) with videos related to
Sort By:
Pageof 35
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.Journal of Thrombosis and Haemostasis : JTH|February 1, 2022
Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factorsGodfrey S Temba, Nadira Vadaq, Jun Wan, et al.European Stroke Journal|July 12, 2023
Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19Adrian Scutelnic, Anita van de Munckhof, Katarzyna Krzywicka, et al.Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.The New England Journal of Medicine|March 21, 2019
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary EmbolismLiselotte M van der Pol, Cecile Tromeur, Ingrid M Bistervels, et al.The Lancet. Haematology|December 9, 2017
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trialArina J Ten Cate-Hoek, Elham E Amin, Annemieke C Bouman, et al.The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.Trials|May 8, 2015
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialPaulien G de Jong, Siobhan Quenby, Kitty W M Bloemenkamp, et al.Pageof 35